Major Manufacturing Facility Projects Set to Open in 2026

Manufacturing construction spending in the US has declined after peaking in 2024. Companies canceled over $32 billion in clean energy manufacturing projects in 2025 due to reduced government incentives, funding cuts, and tariff policy changes, according to E2 data.

Despite this pullback, several industry leaders have announced significant US investments. Taiwan Semiconductor Manufacturing Co. committed $100 billion for three new fabrication plants, two advanced packaging facilities, and a research center. Micron revealed plans for a $200 billion investment across Idaho, New York, and Virginia for semiconductor manufacturing plants and research facilities.

These investments stem partly from federal policies that incentivize domestic production and from funding from the CHIPS and Science Act, along with state and local tax credits for job creation. The projects combine new facility construction with existing plant expansions.

Micron Breaks Ground on New York Memory Chip Facility

Micron’s memory manufacturing facility in New York broke ground in January 2026, with production at the Idaho site expected to begin in 2027. The company is investing $200 billion across multiple facilities, allocating $150 billion for fabrication plants and $50 billion for research and development.

The project includes two fabrication plants in Idaho, four in New York, and expansion of its existing Virginia manufacturing facility. The initiative aims to produce 40% of the company’s dynamic random access memory domestically and is estimated to create 90,000 direct and indirect jobs.

The announcement came in partnership with the US Department of Commerce, which provided $6.4 billion in funding through the CHIPS and Science Act. This funding supports domestic semiconductor production capacity.

Samsung Electronics Resumes Texas Semiconductor Plant

Samsung’s semiconductor manufacturing plant in Taylor, Texas, represents the largest foreign investment in the state, with an initial minimum investment of $17 billion. Construction, which was halted in 2024 due to reduced demand, resumed in mid-2025. The factory is expected to be operational in 2026, creating an estimated 1,800 jobs within a decade.

Samsung initially planned $44 billion worth of investment in Texas, for which it was granted $6.4 billion in CHIPS Act funding. As the company reduced its investment to $37 billion, funding was cut to $4.7 billion. The project is part of a broader expansion in the region, where Samsung has invested over $47 billion since the 1970s.

For manufacturers tracking capital investment trends, understanding how major players adjust project scope in response to market conditions provides insight into strategic planning during economic uncertainty.

Stellantis Plans $13 Billion Multi-State Vehicle Production Expansion

Stellantis is investing $13 billion across Illinois, Indiana, Michigan, and Ohio to expand production by 50% over the next four years. In Indiana, the company will begin producing a new four-cylinder engine in 2026. Illinois will see the facility reopening and production of two new Jeep vehicles in 2027.

Michigan projects include retooling the Warren Truck Assembly Plant for a new range-extended electric vehicle and large SUV expected by 2028. The Detroit Assembly Complex will produce the next-generation Dodge Durango by 2029. This represents the company’s biggest US investment and is expected to create over 5,000 jobs.

Eli Lilly Begins Construction on Alabama Pharmaceutical Facility

Eli Lilly is set to begin construction on its $6 billion active pharmaceutical ingredient manufacturing facility in Huntsville, Alabama, in 2026. The plant is part of the company’s $27 billion investment to build four new pharmaceutical production facilities across the US.

Confirmed sites include a $6.5 billion plant in Houston, expected to be operational within roughly five years after construction begins. A second site, a $5 billion cancer drug facility in Richmond, Virginia, is also expected to be completed in five years. Together, the projects fall under the company’s broader plan to invest $50 billion in expanding domestic production, described as the largest pharmaceutical investment in US history.

The pharmaceutical sector’s expansion reflects growing emphasis on domestic supply chain resilience. According to the US Bureau of Economic Analysis, pharmaceutical manufacturing contributed $150 billion to US GDP in 2024.

Texas Instruments Expands Utah Semiconductor Manufacturing

Texas Instruments is investing $11 billion to expand semiconductor manufacturing with a new 300-millimeter fabrication plant in Lehi, Utah. The new facility will be located next to the company’s existing plant, which it acquired from Micron in 2021. Production is targeted to begin in 2026, creating about 800 direct jobs and thousands of indirect jobs in coming years.

Rivian Moves Forward with Georgia Electric Vehicle Plant

Despite policy changes affecting certain incentives, electric vehicle maker Rivian has started working on a long-delayed $5 billion facility in Stanton Springs, Georgia. Construction is expected to ramp up in 2026, and the 9-million-square-foot site is scheduled to produce 400,000 vehicles annually by 2028.

The company is slated to receive $1.5 billion in state incentives if it creates 7,500 jobs paying an average of at least $56,000 annually.

Capital Investment Planning Considerations for Manufacturers

Major facility announcements demonstrate how manufacturers balance government incentives, market demand, and long-term capacity planning. For companies evaluating expansion opportunities, understanding available federal and state incentives, workforce availability, and infrastructure requirements becomes essential to project feasibility.

The CHIPS Act and state-level tax credits continue to influence location decisions for capital-intensive projects. Manufacturers should assess how policy changes affect project economics and adjust investment timelines accordingly.

Looking to strengthen your plant’s financial performance and long-term strategy? Our advisors help manufacturers manage margins, plan capital investments, and support profitable growth. Connect with our manufacturing team.

All content provided in this article is for informational purposes only. Matters discussed in this article are subject to change. For up-to-date information on this subject please contact a James Moore professional. James Moore will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within these pages or any information accessed through this site.